Compound details
Sachaliside 2
| Compound ID | CDAMM02451 |
|---|---|
| Common name | Sachaliside 2 | IUPAC name | 2-[[2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-6-[3-(4-hydroxyphenyl)prop-2-enyl]-3,4-dihydro-2H-chromen-7-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol |
| Molecular formula | C30H32O12 |
| Retention time | 0.47 |
|---|---|
| Adduct | [2M+K]+ |
| Actual mz | 1207.34 | Theoretical mz | 1207.34 |
| Error | 1.53 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 6.5956 |
| Inchi key | DUZQFCJYWSXVJS-DWZKGKKHNA-N |
|---|---|
| Smiles | OC1=CC=C(C=C1)C=CCC=2C(O)=C3C(OC(C4=CC=C(O)C(O)=C4)C(O)C3)=CC2OC5OC(CO)C(O)C(O)C5O |
| Superclass | Phenylpropanoids and polyketides |
| Class | Flavonoids |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P15692 | VEGFA | Vascular endothelial growth factor A | T20761 | SEA |
| P05230 | FGF1 | Acidic fibroblast growth factor | T18639 | SEA |
| P09038 | FGF2 | Basic fibroblast growth factor | T31621 | SEA |
| P01112 | HRAS | Transforming protein p21/H-Ras-1 | T71081 | SEA |
| P60568 | IL2 | Interleukin-2 | T61698 | SEA |
| P49763 | PGF | Placenta growth factor | T70792 | SEA |
| P14679 | TYR | Tyrosinase | T97035 | SEA |
| P52209 | PGD | 6-phosphogluconate dehydrogenase | T76497 | SEA |
| Q9NZ08 | ERAP1 | Endoplasmic reticulum aminopeptidase 1 | T72849 | SEA |
| P30837 | ALDH1B1 | Acetaldehyde dehydrogenase | T99641 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T20761 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P15692 | VEGFA |
| T20761 | DI0365 | Retinopathy | [ICD-11: 9B71] | P15692 | VEGFA |
| T20761 | DI0430 | Vascular system developmental anomaly | [ICD-11: LA90] | P15692 | VEGFA |
| T18639 | DI0081 | Chronic arterial occlusive disease | [ICD-11: BD4Z] | P05230 | FGF1 |
| T18639 | DI0102 | Coronary atherosclerosis | [ICD-11: BA52] | P05230 | FGF1 |
| T31621 | DI0005 | Acne vulgaris | [ICD-11: ED80] | P09038 | FGF2 |
| T61698 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | P60568 | IL2 |
| T61698 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P60568 | IL2 |
| T70792 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P49763 | PGF |
| T97035 | DI0007 | Acquired hypermelanosis | [ICD-11: ED60] | P14679 | TYR |
| T97035 | DI0008 | Acquired hypomelanotic disorder | [ICD-11: ED63] | P14679 | TYR |
| T76497 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P52209 | PGD |
| T99641 | DI0396 | Substance abuse | [ICD-11: 6C40] | P30837 | ALDH1B1 |